Karthik Musunuri

Karthik Musunuri is a founder and the Chief Executive Officer of Advaite. Advaite is an innovative biotech company headquartered in Malvern, PA with an additional high complexity CLIA laboratory in Chicago, IL, focused on developing novel diagnostics and therapeutics with a current emphasis on delivering assays to help combat COVID-19. Karthik’s experience in big pharma includes R&D clinical development at GSK where he successfully worked on late- stage Phase II/III clinical studies within the respiratory and immunoinflammatory therapeutic areas; and played a key role in the data analysis of the TRELEGY Phase III study. He also held a commercial role within vaccines at GSK by senior leadership leadership as a top performer who contributed to the Shingrix® manufacturing and supply strategy. He also held a commercial role of increasing responsibility at Merck within chronic care, managing a top 5 revenue-generating territory for the multi-billion-dollar chronic care franchise and leading the northeast in sales performance metrics. In addition, Karthik worked at LexisNexis and QuintilesIMS in market research and risk analyses and handled numerous projects within the life sciences and healthcare space. He is passionate about improving human health and making a difference in healthcare.